期刊文献+

血小板抗体及标志物检测在特发性血小板减少性紫癜患者诊断中的价值 被引量:3

The diagnosis value of platelet-associated immunoglobulin G and the platelet ac tivation glycoproteins in patients with idiopathic thrombocytopenic purpura
原文传递
导出
摘要 目的 探讨血小板相关抗体 (PAIgG )和血小板活化标志物GPⅡb/Ⅲa及CD62P表达在特发性血小板减少性紫癜 (ITP)患者中诊断价值。方法 采用流式细胞术分别对ITP患者及各对照组的PAIgG、GPⅡb/Ⅲa及CD62P的表达情况进行分析测定。 结果 ITP患者组GPⅡb/Ⅲa血小板阳性表达率明显高于其他各组 (P <0 0 1) ,CD62P血小板阳性表达率 4组间差异无显著意义 (P >0 0 5) ;在 53例ITP患者中 ,3 4例表现为PAIgG阳性血小板百分率增高 (64 2 % ) ,3 8例表现为平均荧光强度 (MFI)增高 (71 7% ) ,将PAIgG与MFI综合统计 ,对ITP患者阳性诊断率为 84 9% (45/53 ) ;无临床症状ITP患者的GPⅡb/Ⅲa活性表达明显高于有临床症状ITP患者 (P <0 0 1)。结论 PAIgG对ITP诊断具有较高的阳性率 ,同时结合GPⅡb/Ⅲa ,可提高ITP的诊断正确率 ;GPⅡb/Ⅲa可作为ITP患者疗效监测及判断预后的指标 ;CD62P并非监测ITP患者血小板活化的理想标志物。 Objective To study on the diagnosis value of platelet- associated immunoglobulin G (PAIgG) and the platelet activation glycoproteins CD62P、GPⅡb/Ⅲa in the patients with idiopathic thrombocytopenic purpura (ITP). Methods The expression of PAIgG、CD62P and GPⅡb/Ⅲa in patients with ITP and control groups were detected by use of flow cytometry (FCM). Results The expression of GP Ⅱb/Ⅲa in patients with ITP was significantly higher than that of the other groups, but the expression of CD62P was no different in the four groups( P >0 05). In 53 ITP patients, the positive rate of PAIgG was 64 2% (34/53), the positive rate of mean fluorescence intensity (MFI) was 71 7% (38/53), the positive rate of both PAIgG and MFI was 84 9% (45/53). The expression of GPⅡb/Ⅲa in ITP group without clinical symptoms was significantly higher than that in ITP group with clinical symptoms ( P <0 01).Conclusion In ITP patients, positive rate of PAIgG was higher, the correct diagnostic rate of ITP was improved if PAIgG was combined with GPⅡb/Ⅲa; GPⅡb/Ⅲa can be considered as a marker for curing effect and judging prognosis. CD62P was not an ideal marker for platelet activation.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2003年第12期758-760,共3页 Chinese Journal of Laboratory Medicine
基金 山东省科委科研基金资助项目(2002BB1CJA8)
关键词 血小板抗体 检测 特发性血小板减少性紫癜 诊断 血小板活化标志物 Blood platelets Purpura, thombocytopenic, idiopathic
  • 相关文献

同被引文献21

  • 1张丽娜.巨细胞病毒感染与儿童特发性血小板减少性紫癜的关系[J].江苏医药,2005,31(2):140-140. 被引量:13
  • 2朱永生,郭祥,葛娟,何祚光.小儿特发性血小板减少紫癜96例分析[J].江苏医药,2005,31(5):398-399. 被引量:2
  • 3中华医学会血液学学会血栓与止血学组.几种出血性疾病诊断(及疗效)标准的修订[J].中华血液学杂志,1995,16:331-331.
  • 4张之南.血液病学[M].北京:人民卫生出版社,2003.1101-1106.
  • 5Lazarus AH, Ellis J, Semple JW, et al. Comparison of platelet immunity in patients with ITP[J~. Transfus Sci, 2000,22( 1 ) : 19 -27.
  • 6Panzer S,Szamait S,Bodeker RH,et al.Platelet-associated immunoglobulin IgG,IgM,IgA and complement C3 in immune and nonimmune thrombocytopenic disorders[J].Am J Hematol,1986,23(2):89-99.
  • 7Hauber AB,Johnson FR,Grotzinger KM,et al.Patients’’benefit-risk preferences for chronic idiopathic thrombocytopenic purpura therapies. Annals of Pharmacotherapy . 2010
  • 8Yadav D,Chandra J,Sharma S,et al.Short-course high-dosedexamethasone therapy for chronic idiopathic thrombocytopenicpurpura in children. Journal of Tropical Pediatrics . 2010
  • 9Matsubara K,Nigami H,Harigaya H,et al.Combination therapywith low dose CsA,azathiopurin,and prednisolone for a child withrefractory chronic idiopathic thrombocytopenic purpura. RinshoKetsaeki . 2007
  • 10Gernsheimer T.Chronic idiopathic thrombocytopenic purpura:mechanisms of pathogenesis. The Oncologist . 2009

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部